MEM INST OSWALDO CRUZ, RIO DE JANEIRO, 110(4) June 2015
PAGES: 468-475 DOI: 10.1590/0074-02760150024 Full paper
Trypanosoma evansi is alike to Trypanosoma brucei brucei in the subcellular localisation of glycolytic enzymes

S Andrea Moreno1,+, Mayerly Nava2

1Departamento de Biología, Facultad de Ciencias, Universidad de Los Andes, Mérida, Mérida, Venezuela
2Departamento de Biología, Facultad Experimental de Ciencias, Universidad del Zulia, Maracaibo, Zulia, Venezuela

Abstract

Trypanosoma evansi, which causes surra, is descended from Trypanosoma brucei brucei, which causes nagana. Although both parasites are presumed to be metabolically similar, insufficient knowledge of T. evansi precludes a full comparison. Herein, we provide the first report on the subcellular localisation of the glycolytic enzymes in T. evansi, which is a alike to that of the bloodstream form (BSF) of T. b. brucei: (i) fructose-bisphosphate aldolase, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), hexokinase, phosphofructokinase, glucose-6-phosphate isomerase, phosphoglycerate kinase, triosephosphate isomerase (glycolytic enzymes) and glycerol-3-phosphate dehydrogenase (a glycolysis-auxiliary enzyme) in glycosomes, (ii) enolase, phosphoglycerate mutase, pyruvate kinase (glycolytic enzymes) and a GAPDH isoenzyme in the cytosol, (iii) malate dehydrogenase in cytosol and (iv) glucose-6-phosphate dehydrogenase in both glycosomes and the cytosol. Specific enzymatic activities also suggest that T. evansi is alike to the BSF of T. b. brucei in glycolytic flux, which is much faster than the pentose phosphate pathway flux, and in the involvement of cytosolic GAPDH in the NAD+/NADH balance. These similarities were expected based on the close phylogenetic relationship of both parasites.

The Trypanosoma brucei clade (order Kinetoplastida, family Trypanosomatidae, subgenus Trypanozoon) includes five genetically similar (Lai et al. 2008, Lun et al. 2010) parasites: Trypanosoma brucei brucei, which causes nagana in nonhuman mammals in sub-Saharan Africa (Finelle 1983), Trypanosoma evansi, which causes surra in nonhuman mammals throughout the tropics and subtropics (Desquesnes et al. 2013), Trypanosoma brucei gambiense and Trypanosoma brucei rhodesiense, which cause sleeping sickness in humans in sub-Saharan Africa (Simarro et al. 2010), Trypanosoma equiperdum, which causes dourine in equines worldwide (Zablotskij et al. 2003) and T. evansi, which causes surra (mal de cadeiras in Brazil, mal de caderas in Argentina, derrengadera in Venezuela, murrina in Central America) in nonhuman mammals throughout the tropics and subtropics (Desquesnes et al. 2013).

T. evansi is thought to be descended from T. b. brucei, from which it differs in the complete loss of kinetoplast maxicircles, which are involved in the morphological transformation and multiplication within tsetse flies, thus causing a dependence on these endemic Sub-Saharan vectors (Lun & Desser 1995, Lai et al. 2008). A shift to a purely mechanical transmission through the bite of cosmopolitan genera of haematophagous flies may have allowed T. evansi to spread throughout the tropics and subtropics (Lun & Desser 1995). In addition, T. evansi differs from T. b. brucei in possessing: (i) a kinetoplast with one extremely predominant minicircle sequence class, as opposed to a kinetoplast with hundreds of classes (Li et al. 2006) and (ii) an ATP synthase partly lacking a F0 domain, and having a F1 domain hydrolysing ATP to ADP in the mitochondrial matrix and thus, together with an ATP-4/ADP-3 electrogenic transporter, participating in the maintenance of the inner mitochondrial membrane potential (Schnaufer et al. 2005).

With regard to glycolytic metabolism, both parasites are known to be alike in (i) experiencing exponential population growth in the bloodstream of rats and mice in the course of infection (Queiroz et al. 2000, Seed & Wenck 2003), (ii) reducing the blood glucose concentration in infected mammals during such growth (Seed & Wenck 2003, Abdelrahman et al. 2004, Albert et al. 2005, Cadioli et al. 2006, Kumar et al. 2009), (iii) generating pyruvate through glucose consumption as the main product under aerobic conditions (Marshall 1948, Ryley 1956, Grant & Fulton 1957, Haanstra et al. 2012) and (iv) lacking dependence on oxidative phosphorylation to produce ATP during glucose consumption (Evans & Brown 1971, Njogu et al. 1980, Lai et al. 2008).

A substantial gap in the knowledge of T. evansi precludes a full comparison with the metabolism of T. b. brucei. For example, the energetic balance of glycolysis and the structural and kinetic properties of glycolytic enzymes and their inhibitors have not been studied in T. evansi. These enzymes are of special interest as potential targets for therapeutic drugs to treat African trypanosomiasis (Verlinde et al. 2001, Haanstra et al. 2011). Our objective is to reduce this gap by determining for the first time whether T. evansi is alike to the bloodstream form (BSF) of its close relative, T. b. brucei, regarding the subcellular localisation and specific activities of glycolytic enzymes.

 

MATERIALS AND METHODS

This study was performed in accordance with the principles of laboratory animal care of our institution, the Venezuelan laws and the international laws, such as the EU Directive 2010/63/EU for animal experiments.

Our stock of T. evansi (TeAp-N/D1) (Perrone et al. 2009) originated from horses in the Venezuelan Llanos region, where equine trypanosomiasis is endemic (Moreno et al. 2013). We cultured parasites in Sprague-Dawley rats inoculated intraperitoneally with 100 µL of rat blood containing live T. b. evansi at a concentration of 3.6 × 108 parasites/mL. We used phosphate buffer saline (PBS), pH 8.1 (Lanham & Godfrey 1970), to dilute (50%) infected rat blood samples, which we stored in liquid nitrogen until use in subsequent inoculations.

We use the following enzyme abbreviations: fructose-bisphosphate aldolase (ALD), enolase (ENO), glycerol-3-phosphate dehydrogenase (G3PDH), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), glutamate-oxaloacetate transaminase (GOT), glucose-6-phosphate dehydrogenase (GPD), hexokinase (HK), lactate dehydrogenase (LD), malate dehydrogenase (MD), phosphofructokinase (PFK), glucose-6-phosphate isomerase (PGI), phosphoglycerate kinase (PGK), phosphoglycerate mutase (PGM), pyruvate kinase (PK) and triosephosphate isomerase (TIM).

Localisation of glycolytic enzymes in subcellular fractions - We used 20 infected rats. By means of a Neubauer haemocytometer, we estimated the concentration of parasites in rat-tail blood samples. When the density of T. evansi in blood reached 109 parasites/mL, we anesthetised the rats using diethyl ether and sacrificed them by exsanguination using cardiac puncture with a 12 cc syringe previously containing 1 mL of PBSG (57 mM Na2HPO4, 3 mM NaH2PO4, 43.8 mM NaCl, 1% glucose at pH 8.1), to which we added 3.5% sodium citrate. We centrifuged the blood so obtained at 750 g for 10 min at ~23ºC to separate the cells from the plasma. Thereafter, we washed the cell pellet twice with PBSG and eliminated most of the erythrocyte layer by suction with a Pasteur pipette connected to a low vacuum system. We resuspended the remainder of the pellet in PBSG. We passed this eluate through a diethylaminoethyl (DEAE) cellulose column previously equilibrated with PBSG (Lanham & Godfrey 1970). Because the blood cells are retained by DEAE cellulose, this process results in purified parasites contained in a new eluate, which we centrifuged at 3,000 g and 10ºC for 15 min to obtain a T. evansi pellet which we kept in ice until use in further procedures. These involved several techniques, namely selective membrane permeabilisation with digitonin, differential centrifugation and isopycnic ultracentrifugation to obtain purified glycosomes, whose products we evaluated through spectrophotometry and by means of western blot (WB) analysis to determine the subcellular localisation of: (i) glycolytic enzymes, (ii) the glycolysis-auxiliary enzyme G3PDH, (iii) the cytosol marker enzymes MD and GOT and (iv) the dual marker (cytosol and glycosome) enzyme GPD.

Selective membrane permeabilisation with digitonin (Steiger et al. 1980) involved re-suspension of the T. evansi pellet in buffer A [25 mM Tris-HCl, pH 7.4, with added sucrose and ethylenediamine tetraacetic acid (EDTA) to obtain final concentrations of 250 mM and 1 mM, respectively] to obtain a parasite protein concentration of 1 mg/mL. Thereafter, we divided the T. evansi suspension in 1.5 mL Eppendorf tubes and added varying amounts (ranging from 0.01-0.6 mg) of digitonin. After incubating the tubes for 30 min, we centrifuged them at 14,000 g for 2 min. After washing them with buffer A, we resuspended the resulting pellets in 200 µL buffer A containing 0.1% v/v of Triton X-100. We determined spectrophotometrically the activity of the enzymes of interest in the supernatant. In addition, we used the pellets and their corresponding supernatants to test for the presence of HK using WB analysis.

Differential centrifugation (Steiger et al. 1980, Taylor & Gutteridge 1987) involved: (i) washing the T. evansi pellet twice with buffer A, (ii) mixing the pellet at a 1:1 proportion with 200 mesh silicate carbide, (iii) adding buffer B (10 mM HEPES pH 7.2, 250 mM sucrose, 25 mM NaCl, 2 mM Na2 EDTA and 5 mM dithiothreitol) containing a protease inhibiting cocktail (57 μM PMSF, 100 μM TLCK, 10 μM leupeptin and 1 mM benzamidine), (iv) breaking the mixture through abrasion in a mortar at 4ºC, (v) centrifuging the mixture at 150 g for 3 min at 4ºC to eliminate the resulting silicate carbide sediment, (vi) centrifuging the supernatant at a 1,000 g for 10 min at 4ºC to obtain an unbroken, parasite and nuclei-rich pellet [nuclear fraction (NF)] and a supernatant, (vii) centrifuging the supernatant at a 5,000 g for 15 min at 4ºC to obtain a mitochondrial and large cellular debris [large granular fraction (LGF)] and a supernatant, (viii) centrifuging the supernatant at 33,000 g for 20 min at 4ºC to obtain a glycosome-rich pellet [small granular fraction (SGF)] and a supernatant, (ix) ultracentrifuging the supernatant at 105,000 g for 90 min at 4ºC to obtain a microsomal pellet [microsomal fraction (MF)] and a supernatant corresponding to the cytosol [cytosolic fraction (CF)], (x) washing the pellets (NF, LGF, SGF, MF) with buffer A and solubilising them in 150 mM of NaCl containing 0.1% Triton X-100, (xi) for NF, LGF, SGF, MF and CF, using Lowry assays to determine protein concentrations (to eliminate potential contaminants, we precipitated the proteins before these assays using 10% trichloroacetic acid) (Rosenberg 2005), (xii) for CF and solubilised NF, LGF, SGF, MF, spectrophotometrically determining the specific activity (sa) of the enzymes of interest and (xiii) for CF and solubilised NF, LGF, SGF, testing for the presence of HK using WB analysis.

To visualise the degree of association of enzymes, as measured by their specific activities, with each other and with the subcellular fractions resulting from differential centrifugation, we used detrended correspondence analysis (DCA). This multivariate statistical technique is an improved variant (Hill & Gauch Jr 1980) of correspondence analysis, a visualisation method picturing the association of rows (in our case enzymes) and columns (in our case subcellular fractions) of a contingency table in a single low-dimensional space, representing the most important relationships (Sourial et al. 2010). For the needed calculations, we used Paleontological Statistics Software Package for Education and Data Analysis v.3.04 (Hammer et al. 2001).

Presence of glycolytic enzymes in purified glycosomes - Purification of glycosomes by means of isopycnic ultracentrifugation (Opperdoes et al. 1984) involved layering the SGF (step 8 of the previously described experiment) onto a linear 0.3-2.5 M sucrose gradient containing buffer A, followed by centrifugation at 170,000 g for 2 h at 4ºC. Thereafter, we removed the layer corresponding to highly purified glycosomes (equilibrated at 1.23 g/cm3) by puncturing the side of the tube with a syringe, divided this layer into two fractions, placed one of them in a 150 mM of NaCl solution containing 0.1% Triton X-100 and determined spectrophotometrically the activity of the enzymes of interest in both fractions. In addition, we tested for the presence of HK by means of WB analysis. We estimated the latency of HK and PGK using the relation l = [(a - b)/a)] × 100, where l = percent latency, a = enzyme activity of glycosomes in 0.1% Triton X-100 and b = enzyme activity outside glycosomes (Steiger et al. 1980).

We spectrophotometrically assayed the enzymes in quartz cuvettes at ~23ºC by detecting the oxidation/reduction of NADPH/NADP+ and NADH/NAD+ at 340 nm in a final volume of 1 mL. One unit (U) of enzyme activity is defined as the amount of the enzyme required to catalyse the formation (transformation) of 1 µmol/min of product (substrate). We followed the procedures of Bergmeyer (1983) for GOT, GPD, MD and PK, Misset & Opperdoes (1984) for ALD, G3PDH, GAPDH, HK, PFK, PGI, PGK and TIM [in the case of PFK we measured the enzymatic activity in absence of allosteric activator (AMP)], Durany et al. (1996) for PGM (the reaction mix contained 100 mM Tris-HCl, pH 7.4, 10 mM KCl, 2 mM MgCl2, 1 mM ADP, 4 mM 3-phosphoglycerate, 0.2 mM NADH, 1.4 U/mL ENO, 1.4 U/mL PK and 5 U/mL LD) and Hannaert et al. (2003b) for ENO.

 

RESULTS

Localisation of glycolytic enzymes in subcellular fractions - Three enzyme groups were distinguished according to their release patterns after selective membrane permeabilisation with digitonin (Fig. 1): (i) MD and ENO, reaching 100% activity at 0.04-0.08 mg/mg of digitonin/protein, thus these enzymes are cytosolic (ENO is a marker enzyme for the cytosol) (Hannaert et al. 2003b), (ii) G3PDH, PGK and HK, reaching 100% activity at 0.18-0.25 mg/mg of digitonin/protein, thus these enzymes are glycosomal (HK is a marker enzyme for glycosomes) (Opperdoes & Borst 1977, Hart et al. 1984, Misset & Opperdoes 1984, Opperdoes et al. 1984, Hammond et al. 1985, Misset et al. 1986) and (iii) PGI and GPD, with a biphasic pattern, thus these enzymes are both cytosolic and glycosomal. In the case of PGI, 12% of its activity was reached at 0.01-0.02 mg/mg of digitonin/protein and 100% of its activity was reached at 0.18-0.25 mg/mg of digitonin/protein. In the case of GPD, 50% of its activity was reached at 0.02-0.04 mg/mg of digitonin/protein and 100% of its activity was reached at 0.25-0.30 mg/mg of digitonin/protein. To confirm the HK release pattern, we applied WB and immunodetection to pellets and supernatants obtained during digitonin permeabilisation of the parasites (Fig. 1). The HK signal disappeared from the pellet at digitonin/protein levels greater than 0.35 mg/mg and became decidedly stronger in the supernatant at digitonin/protein levels 0.20 mg/mg. Recall that HK was in the second enzyme group distinguished above for which 100% activity was reached at 0.18-0.25 mg/mg of digitonin/protein.

 

 

Three enzyme groups were distinguished according to their distributional patterns in the subcellular fractions obtained through differential centrifugation (Fig. 2): (i) HK, PGK, PFK, G3PDH, ALD, PGI and TIM, with maximum sa in the glycosome-rich pellet (SGF), (ii) GAPDH and GPD, with high specific activities in both the glycosome-rich pellet and the supernatant (CF), and (iii) ENO, MD, GOT, PK and PGM, with maximum sa in the supernatant. To confirm the distributional pattern of HK through differential centrifugation, we applied WB analysis and immunodetection (Fig. 2, top left). As expected, the HK signal was highest in SGF and weakest in CF. The rupture of some glycosomes might account for the weak HK signal in CF.

Multivariate analysis (Fig. 3) confirmed the visual observation (Fig. 2) of a group of primarily glycosomal enzymes (ALD, G3PDH, HK, PFK, PGI, PGK, TIM), a group of primarily cytosolic enzymes (ENO, GOT, MD, PGM, PK) and a group of simultaneously glycosomal and cytosolic enzymes (GAPDH, GPD). Multivariate analysis (Fig. 3) also indicated that glycosomal enzymes are most closely associated with LGF and SGF, that cytosolic enzymes are almost exclusively associated with CF and that most enzymes are not or are weakly associated with NF and, particularly, with MF. The eigenvalue (0.3315) for axis 1 was much higher than the eigenvalue (0.0237) for axis 2 (eigenvalues for axes 3 and 4 were 0.0088 and 0.0016, respectively), indicating that the transition from LGF and SGF to CF, represented by axis 1, is more important than the transition from LGF, SGF and CF to MF, represented by axis 2 (Fig. 3). Therefore, axis 1 was sufficient to represent enzyme concomitances along the examined fractions.

 

 

Presence of glycolytic enzymes in purified glycosomes - The results obtained using selective membrane permeabilisation with digitonin and differential centrifugation suggest the presence of eight enzymes in glycosomes. To corroborate this result, we evaluated the sa of these enzymes in purified glycosomes obtained through isopycnic ultracentrifugation. The mean sa values (U/mg) measured in purified glycosomes are shown in Table. In addition, we used WB analysis to corroborate the presence of HK in purified glycosomes (Fig. 2, top left). The latency of HK is 90% and that of PGK is 85%.

 

 

DISCUSSION

Localisation of glycolytic enzymes in subcellular fractions - T. evansi (this study) and T. b. brucei (previous studies) are similar in several enzyme release patterns determined through selective membrane permeabilisation with digitonin (Fig. 1). In T. evansi, ENO and MD are fully released at a digitonin concentration (0.04 mg/mg digitonin/protein) similar to that required for the permeabilisation of the T. b. brucei cell membrane (Visser & Opperdoes 1980, Besteiro et al. 2002), suggesting that these enzymes are cytosolic in both parasites. In T. evansi, G3PDH, PGK and HK are fully released at a digitonin concentration (0.20 mg/mg) similar to that required for the permeabilisation of the T. b. brucei glycosomes (Besteiro et al. 2002), suggesting that these enzymes are glycosomal in both parasites. We observed that the release of G3PDH and PGK started at a slightly lower digitonin concentration than HK, suggesting that the latter is part of a crystalloid nucleus, as proposed for T. b. brucei (Misset et al. 1986). If G3PDH and PGK were not nuclear, then higher solubilities compared with HK would be expected. In T. evansi, PGI and GPD were released at two different digitonin concentrations, i.e., the concentrations required to permeabilise the cell membrane and glycosomes, suggesting that, similarly to GPD in the BSF and the procyclic (PC) stage of T. b. brucei (Heise & Opperdoes 1999, Duffieux et al. 2000), each of these enzymes consists of one cytosolic and one glycosomal isoenzyme.

T. evansi (this study) and T. b. brucei (previous studies) are similar in several enzyme subcellular distribution patterns determined through differential centrifugation (Figs 2, 3). In T. evansi, HK, PGK, PFK, ALD, PGI, G3PDH and TIM were observed in the glycosome-rich pellet, reproducing findings for the BSF of T. b. brucei (Opperdoes & Borst 1977, Steiger et al. 1980). In T. evansi, GAPDH and GPD were both observed in the glycosome-rich pellet and in the cytosol, reproducing findings for GAPDH in the BSF (Opperdoes & Borst 1977, Steiger et al. 1980) and for GPD in the BSF and PC (Heise & Opperdoes 1999, Duffieux et al. 2000) of T. b. brucei. In T. evansi, ENO, MD, GOT, PK and PGM were observed in the cytosol, reproducing findings for the BSF of T. b. brucei (Opperdoes & Borst 1977, Oduro et al. 1980, Hannaert et al. 2003b, Aranda et al. 2006, Marciano et al. 2008).

Although selective membrane permeabilisation with digitonin indicated a small proportion of PGI activity to be cytosolic (PGI was the only enzyme whose subcellular localisation diverged, albeit slightly, using different methods), multivariate analysis of the differential centrifugation data (Fig. 3) clearly place this enzyme in the glycosomal group.

Presence of glycolytic enzymes in purified glycosomes - T. evansi (this study) and the BSF of T. b. brucei (previous authors) are similar regarding purification factors (3.8-13.8 times vs. 3.1-18.6 times with respect to the homogenate) of eight enzymes and in the specific activities of three enzymes (HK, PGI and PGK) present in the purified glycosomes obtained through isopycnic ultracentrifugation (Table). However, for some enzymes (ALD, G3PDH, GAPDH, PFK and TIM), dissimilar experimental conditions result in different sa values for T. evansi (Table). In the case of ALD, G3PDH, GAPDH and TIM, the sa values were inferior for T. evansi owing to a low ionic strength and the absence of reducing agents in the buffer (the activities of ALD and GAPDH increased five-fold under the opposite conditions) (Misset et al. 1986, 1987). In the case of PFK, the sa for T. evansi was similar to the lowest value for the BSF of T. b. brucei owing to the absence of AMP in the buffer (maximum activity requires the presence of AMP) (Misset & Opperdoes 1984). Notwithstanding some underestimations, the increased specific activities in purified glycosomes with respect to the homogenate of ALD, GAPDH, HK, PFK, PGI and PGK imply that these enzymes are glycosomal. As a control, we verified that there was no activity of the cytosolic enzymes ENO or PK in purified glycosomes.

Concluding remarks - Based on protein homologies, G3PDH, GAPDH, MD and TIM in T. evansi have been inferred to have the same localisation as in T. b. brucei (Roy et al. 2010). The results of two techniques (digitonin permeabilisation, differential centrifugation) implied that, as in the BSF of T. b. brucei, in T. evansi: (i) HK (marker enzyme), ALD, G3PDH, PFK, PGI, PGK and TIM are located in glycosomes, (ii) ENO (marker enzyme), GOT, MD, PGM and PK are located in the cytosol and (iii) GAPDH and GPD are located in both glycosomes and in the cytosol. A third technique (isopycnic ultracentrifugation) confirmed that, as in the BSF of T. b. brucei, in T. evansi, HK, ALD, G3PDH, GAPDH, PFK, PGI and PGK are located in glycosomes and ENO and PK are not.

For T. evansi, as in the BSF of T. b. brucei (Opperdoes 1987), we expected ATP consumption to be catalysed by HK and PFK in glycosomes, and ATP synthesis to be catalysed by PGK in glycosomes and by PK in the cytosol. Moreover, the resemblance regarding the specific activities of HK, PGI and PGK between T. evansi and the BSF of T. b. brucei (Table) suggests glycolytic flux to be alike in both. The localisation of MD (presence in cytosol, absence in mitochondria) in T. evansi was similar to that reported for the BSF of T. b. brucei suggesting lack of an operative Krebs cycle (Aranda et al. 2006).

In T. evansi, the function of the dual localisation of GPD, an enzyme of the oxidative phase of the pentose phosphate pathway, might be similar to that proposed for the BSF of T. b. brucei (Duffieux et al. 2000), namely, synthesising the required reducing power (NADPH) in cytosol and glycosomes. In T. evansi, the specific activities of cytosolic and glycosomal GPD are much lower (217-310 times) than those of glycolytic enzymes (HK, PGI, PGK), suggesting a much slower flux of the pentose phosphate pathway relatively to that of glycolysis, as reported for the BSF of T. b. brucei (Hannaert et al. 2003a). Although it is not known whether host glucose is oxidised through the pentose phosphate pathway in Trypanozoon, the viability of the BSF of T. b. brucei depends on GPD (Cordeiro et al. 2009). Species of Trypanozoon transform glucose into pyruvate (62.8-96.1%), glycerol (0-29%), CO2 (1.7-6.1%), succinate (0-2.9%), lactate (0-2.6%), acetate (0-1.7%) and citrate (0-1.2%) under aerobic conditions (Ryley 1956). Thus, the CO2 released by these species might partly result from glucose oxidation in the pentose phosphate pathway.

Evolutionary, cytosolic and glycosomal GAPDH may have been independently acquired (Michels et al. 1991). The function of cytosolic GAPDH is unknown. In T. evansi, as in the BSF of T. b. brucei (Opperdoes & Borst 1977), glycosomal GAPDH is likely to be a glycolytic enzyme having a much lower affinity for NADH and NAD+ than cytosolic GAPDH (Lambeir et al. 1991). Therefore, cytosolic GAPDH should be involved in the NAD+/NADH balance of T. evansi and the BSF of T. b. brucei, as shown for Leishmania donovani (Zhang et al. 2013). The exchange of phosphorylated intermediates of glycolysis between glycosomes and the cytosol at a rate 60 times lower than glycolytic flux (Visser et al. 1981) is consistent with this hypothesis. Pore-forming channels might be involved (Gualdrón-López et al. 2012). A similar mechanism might explain how glucose-6-phosphate, catalytically produced by HK in glycosomes, can become a substrate for GPD in the cytosol in both T. evansi and T. b. brucei.

Owing to their close phylogenetic relationship and because maxicircles are not needed to thrive in blood, T. evansi and the BSF of T. b. brucei are expected to be metabolically similar (Lai et al. 2008), as our results have shown for the glycolytic pathway.

 

ACKNOWLEDGEMENTS

To Jesús Molinari, for comments.

 

REFERENCES

Abdelrahman SH, Elmalik KH, Khalid HS, Shamat AMA, Khojali SME 2004. Biochemical changes in rats experimentaly infected with Trypanosoma evansi. J Anim Vet Adv 3: 483-486.

Albert MA, Haanstra JR, Hannaert V, Roy JV, Opperdoes FR, Bakker BM, Michels PAM 2005. Experimental and in silico analyses of glycolytic flux control in bloodstream form Trypanosoma brucei. J Biol Chem 280: 28306-28315.

Aranda A, Maugeri D, Uttaro AD, Opperdoes FR, Cazzulo JJ, Nowicki C 2006. The malate dehydrogenase isoforms from Trypanosoma brucei: subcellular localization and differential expression in bloodstream and procyclic forms. Int J Parasitol 36: 295-307.

Bergmeyer HU 1983. Methods of enzymatic analysis, Verlag Chemie, Weinheim, 539 pp.

Besteiro S, Biran M, Biteau N, Coustou V, Baltz T, Canioni P, Bringaud F 2002. Succinate secreted by Trypanosoma brucei is produced by a novel and unique glycosomal enzyme, NADH-dependent fumarate reductase. J Biol Chem 277: 38001-38012.

Cadioli FA, Marques LC, Machado RZ, Alessi AC, Aquino LPCT, Barnabé PA 2006. Experimental Trypanosoma evansi infection in donkeys: hematological, biochemical and histopathological changes. Arq Bras Med Vet Zootec 58: 749-756.

Cordeiro AT, Thiemann OH, Michels PA 2009. Inhibition of Trypanosoma brucei glucose-6-phosphate dehydrogenase by human steroids and their effects on the viability of cultured parasites. Bioorg Med Chem 17: 2483-2489.

Desquesnes M, Holzmuller P, Lai DH, Dargantes A, Lun ZR, Jittaplapong S 2013. Trypanosoma evansi and surra: a review and perspectives on origin, history, distribution, taxonomy, morphology, hosts and pathogenic effects. Biomed Res Int 2013: 194176.

Duffieux F, Roy JV, Michels PAM, Opperdoes FR 2000. Molecular characterization of the first two enzymes of the pentose-phosphate pathway of Trypanosoma brucei glucose-6-phosphate dehydrogenase and 6-phosphogluconolactonase. J Biol Chem 275: 27559-27565.

Durany N, Carballo E, Joseph J, Bedini JL, Bartrons R, Ballesta AM, Carreras J 1996. Activity of phosphoglycerate mutase and its isoenzymes in serum after acute myocardial infarction. Clin Mol Pathol 49: M298-M300.

Evans DA, Brown RC 1971. Cyanide insensitive culture form of Trypanosoma brucei. Nature 230: 251-252.

Finelle P 1983. Chemoprophylaxis and the raising of trypanotolerant livestock. In African animal trypanosomiasis - selected articles from the world animal review, Animal Production and Health Paper, Vol. 37, FAO, Roma, p. 1-14.

Grant PT, Fulton JD 1957. The catabolism of glucose by strains of Trypanosoma rhodesiense. Biochem J 66: 242-250.

Gualdrón-López M, Vapola MH, Miinalainen IJ, Hiltunen JK, Michels PAM, Antonenkov VD 2012. Channel-forming activities in the glycosomal fraction from the bloodstream form of Trypanosoma brucei. PLoS ONE 7: e34530.

Haanstra JR, Kerkhoven EJ, van Tuijl A, Blits M, Wurst M, van Nuland R, Albert MA, Michels PAM, Bouwman J, Clayton C, Westerhoff HV, Bakker BM 2011. A domino effect in drug action: from metabolic assault towards parasite differentiation. Mol Microbiol 79: 94-108.

Haanstra JR, van Tuijl A, van Dam J, van Winden W, Tielens AG, van Hellemond JJ, Bakker BM 2012. Proliferating bloodstream-form Trypanosoma brucei use a negligible part of consumed glucose for anabolic processes. Int J Parasitol 42: 667-673.

Hammer Ø, Harper DAT, Ryan PD 2001. PAST: Paleontological Statistics Software Package for Education and Data Analysis. Palaeontol Electronica 4: 1-9.

Hammond DJ, Aman RA, Wang CC 1985. The role of compartmentation and glycerol kinase in the synthesis of ATP within the glycosome of Trypanosoma brucei. J Biol Chem 260: 15646-15654.

Hannaert V, Albert M-A, Rigden DJ, Giotto MTS, Thiemann O, Garratt RC, Roy JV, Opperdoes FR, Michels PAM 2003a. Evolution of energy metabolism and its compartmentation in Kinetoplastida. Kinetoplastid Biol Dis 2: 1-30.

Hannaert V, Albert MA, Rigden DJ, Giotto TS, Thiemann O, Garratt R, Roy JV, Opperdoes FR, Michels PAM 2003b. Kinetic characterization, structure modelling studies and crystallization of Trypanosoma brucei enolase. Eur J Biochem 270: 3205-3213.

Hart DT, Misset O, Edwards SW, Opperdoes FR 1984. A comparison of the glycosomes (microbodies) isolated from Trypanosoma brucei bloodstream form and cultured procyclic trypomastigotes. Mol Biochem Parasitol 12: 25-35.

Heise N, Opperdoes FR 1999. Purification, localisation and characterisation of glucose-6-phosphate dehydrogenase of Trypanosoma brucei. Mol Biochem Parasitol 99: 21-32.

Hill MO, Gauch Jr HG 1980. Detrended correspondence analysis: an improved ordination technique. Vegetatio 42: 47-58.

Kumar U, Jas R, Ghosh JD 2009. Effect of isometamidium hydrochloride on Trypanosoma evansi infections in rats. J Parasit Dis 33: 36-41.

Lai DH, Hashimi H, Lun ZR, Ayala FJ, Lukeš J 2008. Adaptations of Trypanosoma brucei to gradual loss of kinetoplast DNA: Trypanosoma equiperdum and Trypanosoma evansi are petite mutants of T. brucei. Proc Natl Acad Sci USA 105: 1999-2004.

Lambeir AM, Loiseau AM, Kuntz DA, Vellieux FM, Michels PA, Opperdoes FR 1991. The cytosolic and glycosomal glyceraldehyde-3-phosphate dehydrogenase from Trypanosoma brucei. Eur J Biochem 198: 429-435.

Lanham SM, Godfrey DG 1970. Isolation of salivarian trypanosomes from man and other mammals using DEAE-cellulose. Exp Parasitol 28: 521-534.

Li FJ, Lai DH, Lukeš J, Chen XG, Lun ZR 2006. Doubts about Trypanosoma equiperdum strains classed as Trypanosoma brucei or Trypanosoma evansi. Trends Parasitol 22: 55-56.

Lun ZR, Desser SS 1995. Is the broad range of hosts and geographical distribution of Trypanosoma evansi attributable to the loss of maxicircle kinetoplast DNA? Parasitol Today 11: 131-133.

Lun ZR, Lai DH, Li FJ, Lukeš J, Ayala FJ 2010. Trypanosoma brucei: two steps to spread out from Africa. Trends Parasitol 26: 424-427.

Marciano D, Llorente C, Maugeri DA, de la Fuente C, Opperdoes FR, Cazzulo JJ, Nowicki C 2008. Biochemical characterization of stage-specific isoforms of aspartate aminotransferases from Trypanosoma cruzi and Trypanosoma brucei. Mol Biochem Parasitol 161: 12-20.

Marshall PB 1948. The glucose metabolism of Trypanosoma evansi and the action of trypanocides. Br J Pharmacol 3: 8-14.

Michels PAM, Marchand M, Kohl L, Allert S, Wierenga RK, Opperdoes FR 1991. The cytosolic and glycosomal isoenzymes of glyceraldehyde-3-phosphate dehydrogenase in Trypanosoma brucei have a distant evolutionary relationship. Eur J Biochem 198: 421-428.

Misset O, Beeumen J, Lambeir A-M, van der Meer R, Opperdoes FR 1987. Glyceraldehyde-phosphate dehydrogenase from Trypanosoma brucei. Eur J Biochem 162: 501-507.

Misset O, Bos OJ, Opperdoes FR 1986. Glycolytic enzymes of Trypanosoma brucei. Eur J Biochem 157: 441-453.

Misset O, Opperdoes FR 1984. Simultaneous purification of hexokinase, class-I fructose-bisphosphate aldolase, triosephosphate isomerase and phosphoglycerate kinase from Trypanosoma brucei. Eur J Biochem 144: 475-483.

Moreno SA, Concepción JL, Nava M, Molinari J 2013. Importance of the horse and financial impact of equine trypanosomiasis on cattle raising in Venezuela. Trop Anim Health Prod 45: 1669-1676.

Njogu RM, Whittaker CJ, Hill GC 1980. Evidence for a branched electron transport chain in Trypanosoma brucei. Mol Biochem Parasitol 1: 13-29.

Oduro KK, Flynn IW, Bowman IBR 1980. Trypanosoma brucei: activities and subcellular distribution of glycolytic enzymes from differently disrupted cells. Exp Parasitol 50: 123-135.

Opperdoes FR 1987. Compartmentation of carbohydrate metabolism in trypanosomes. Annu Rev Microbiol 41: 127-151.

Opperdoes FR, Baudhuin P, Coppens I, de Roe C, Edwards SW, Weijers PJ, Misset O 1984. Purification, morphometric analysis and characterization of the glycosomes (microbodies) of the protozoan hemoflagellate Trypanosoma brucei. J Cell Biol 98: 1178-1184.

Opperdoes FR, Borst P 1977. Localization of nine glycolytic enzymes in a microbody-like organelle in Trypanosoma brucei: the glycosome. FEBS Lett 80: 360-364.

Perrone TM, Gonzatti MI, Villamizar G, Escalante A, Aso PM 2009. Molecular profiles of Venezuelan isolates of Trypanosoma sp. by random amplified polymorphic DNA method. Vet Parasitol 161: 194-200.

Queiroz AO, Cabello PH, Jansen AM 2000. Biological and biochemical characterization of isolates of Trypanosoma evansi from Pantanal of Matogrosso - Brazil. Vet Parasitol 92: 107-118.

Rosenberg IM 2005. Protein analysis and purification: benchtop techniques, 2nd ed., Birkhäuser, Boston, 520 pp.

Roy N, Nageshan RK, Pallavi R, Chakravarthy H, Chandran S, Kumar R, Gupta AK, Singh RK, Yadav SC, Tatu U 2010. Proteomics of Trypanosoma evansi infection in rodents. PLoS ONE 5: e9796.

Ryley JF 1956. Studies on the metabolism of the protozoa. 7. Comparative carbohydrate metabolism of eleven species of trypanosome. Biochem J 62: 215-222.

Schnaufer A, Clark-Walker GD, Steinberg AG, Stuart K 2005. The F1-ATP synthase complex in bloodstream stage trypanosomes has an unusual and essential function. EMBO J 24: 4029-4040.

Seed JR, Wenck MA 2003. Role of the long slender to short stumpy transition in the life cycle of the African trypanosomes. Kinetoplastid Biol Dis 2: 3.

Simarro PP, Cecchi G, Paone M, Franco JR, Diarra A, Ruiz JA, Fèvre EM, Courtin F, Mattioli RC, Jannin JG 2010. The atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseases. Int J Health Geogr 9: 57-75.

Sourial N, Wolfson C, Zhu B, Quail J, Fletcher J, Karunananthan S, Bandeen-Roche K, Béland F, Bergman H 2010. Correspondence analysis is a useful tool to uncover the relationships among categorical variables. J Clin Epidemiol 63: 638-646.

Steiger RF, Opperdoes FR, Bontemps J 1980. Subcellular fractionation of Trypanosoma brucei bloodstream forms with special reference to hydrolases. Eur J Biochem 105: 163-175.

Taylor MB, Gutteridge WE 1987. Trypanosoma cruzi: subcellular distribution of glycolytic and some related enzymes of epimastigotes. Exp Parasitol 63: 84-97.

Verlinde CL, Hannaert V, Blonski C, Willson M, Périé JJ, Fothergill-Gilmore LA, Opperdoes FR, Gelb MH, Hol WG, Michels PAM 2001. Glycolysis as a target for the design of new anti-trypanosome drugs. Drug Resist Updat 4: 50-65.

Visser N, Opperdoes FR 1980. Glycolysis in Trypanosoma brucei. Eur J Biochem 103: 623-632.

Visser N, Opperdoes FR, Borst P 1981. Subcellular compartmentation of glycolytic intermediates in Trypanosoma brucei. Eur J Biochem 118: 521-526.

Zablotskij VT, Georgiu C, de Waal T, Clausen PH, Claes F, Touratier L 2003. The current challenges of dourine: difficulties in differentiating Trypanosoma equiperdum within the subgenus Trypanozoon. Rev Sci Tech 22: 1087-1096.

Zhang WW, McCall LI, Matlashewski G 2013. Role of cytosolic glyceraldehyde-3-phosphate dehydrogenase in visceral organ infection by Leishmania donovani. Eukaryot Cell 12: 70-77.

 

Financial support: CDCHTA [Ubicación de las enzimas de la glicólisis en el glicosoma del parásito protozoario Trypanosoma evansi (Kinetoplastida, Trypanosomatidae) (C-1873-14-03-B) and Caracterización bioquímica de la fosfoglicerato quinasa de Trypanosoma evansi (C-1397-06-03-B)] (to SAM)
+ Corresponding author: This e-mail address is being protected from spambots. You need JavaScript enabled to view it.
Received 15 January 2015

CONTACT US

Memórias do Instituto Oswaldo Cruz

Av. Brasil 4365, Castelo Mourisco
sala 201, Manguinhos, 21040-900
Rio de Janeiro, RJ, Brazil

Tel.: +55-21-2562-1222

This e-mail address is being protected from spambots. You need JavaScript enabled to view it.

twitterfacebook

SUPPORT PROGRAM

marca fiocruzmarca brasil
marca faperjmarca cnpqmarca capes n marca cope